SGAM
WST icon

Smith Group Asset Management’s West Pharmaceutical WST Stock Holding History

Smith Group Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$31.5M Sell
76,590
-1,893
-2% -$741K 1.66% 15
2021
Q4 		$36.7M Sell
78,483
-3,696
-4% -$1.59M 1.69% 18
2021
Q3 		$34.9M Buy
82,179
+2,466
+3% +$1.04M 1.77% 15
2021
Q2 		$28.6M Sell
79,713
-5,252
-6% -$1.74M 1.4% 23
2021
Q1 		$24M Buy
+84,965
New +$24.3M 1.27% 30

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Smith Group Asset Management's WST Position: Q1 2022 in Review

Smith Group Asset Management reduced its West Pharmaceutical (WST) stake by 2.4% in Q1 2022, selling an estimated $741K and leaving 76,590 shares worth $31.5M. The position accounts for 1.66% of the portfolio, ranked #15.

Smith Group Asset Management first reported a position in WST in Q1 2021 and has held it in 5 quarters since. The position peaked at $36.7M in Q4 2021. 716 funds tracked by Wall St. Rank hold WST as of Q1 2022.

  • Smith Group Asset Management held 76,590 shares of West Pharmaceutical worth $31.5M as of Q1 2022.
  • Smith Group Asset Management sold 1,893 West Pharmaceutical shares in Q1 2022, an estimated $741K.
  • West Pharmaceutical made up 1.66% of Smith Group Asset Management's portfolio in Q1 2022, its #15 holding.
  • Smith Group Asset Management first reported a position in West Pharmaceutical in Q1 2021 and has held it in 5 quarters since.
  • Smith Group Asset Management's West Pharmaceutical position peaked at $36.7M in Q4 2021.
  • 716 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2022.

Based on Smith Group Asset Management's 13F filing for Q1 2022, filed 5 May 2022.